Guillory, Ariahnna .
HRN: 23-80-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
CEFUROXIME 500MG (TAB)
11/16/2023
11/22/2023
PO
500mg
BID
S/P RMLE
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes